Nick Swart recently joined Mtech Access as a Senior Health Economist, following 5 years as a Research Associate in Health Economics at University College London. In this interview, Nick shares...
Read More
Are you looking to launch a new medical technology, medical or diagnostic device in the UK, Europe or North America? Would you like to know how health economic modelling could...
Read More
Challenges for orphan medicines entering the European market – Part 3: Economic evidence development
In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve patient...
Read More
Calum Jones, Consultant Health Economist at Mtech Access, shares his passion for helping MedTech firms build health economic models that help their innovative new technologies reach patients. Tell us about...
Read More
We are delighted to bring you our Pharma Market Access Insights Podcast. In this podcast we will offer insights and thought leadership from the market access and HEOR experts at Mtech...
Read More
Dan Howard and Hannah Gillies from our Health Economics team explore some of the themes from a recent Health Affairs Blog article on the implications of new cell and gene therapies on HTA: ‘Putting The Costs And...
Read More
